Monday, November 25, 2024 11/25/2024

Comprehensive Cancer Center Program at Fox Chase

Award Number: P30CA006927
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By:

View Award Abstract

PROJECT SUMMARY/ABSTRACT – OVERALL The Fox Chase Cancer Center (FCCC), now in its 51st year as an NCI-designated Comprehensive Cancer Center, has undergone a profound transformation since the time of the last CCSG grant review. In 2012, Fox Chase entered into an affiliation with the Temple University Health System, creating a unique new model that combines the flexibility of a free-standing cancer center with the scientific and clinical breadth of a university- based matrix center. In addition to this organizational change, in 2013, FCCC came under new leadership with the appointment of Richard I. Fisher, MD as President and CEO of FCCC and Cancer Center Director. As a result of these developments, the size and scope of the Cancer Center have greatly expanded, both in terms of its scientific enterprise and also in the number and diversity of the patients served. Cancer-focused, Temple faculty members have been thoroughly integrated into FCCC, adding 54 new CCSG members, including three in leadership positions (Jean-Pierre Issa, MD, PhD, Co-Program Leader for Cancer Epigenetics; Susan Fisher, PhD, Associate Director for Population Science; Grace Ma, PhD, Director of Community Based Research). In addition to expanding membership, the affiliation has enabled access to specialized expertise at Temple University, including the Fels Institute for Cancer Research and Molecular Biology, the Moulder Center for Drug Discovery, and the newly created School of Public Health. Importantly, with the affiliation, FCCC now has greatly enhanced access to an underserved population within its catchment area, surrounding the Temple University Health Science Center in North Philadelphia. Other important accomplishments within the last grant cycle include: a) Recruitment of Wafik El-Deiry, MD, PhD to a new Deputy Directorship for Translational Research to enhance the clinical translation of basic research findings; b) A 40% increase in the direct costs of funded research at FCCC from 2013 - 2015 ($27.7M to $38.7M); c) 43-fold return on investment from CCSG- supported pilot projects; d) Increased accrual to treatment interventional trials, from 358 in 2011 to 668 in 2014 (an 87% increase); e) Establishment of a cutting-edge Research Program in Cancer Epigenetics; and f) Publication of more than 2,200 papers from 2011-2015, with strong intra- and inter-programmatic collaboration, including 20% in journals with Impact Factors > 8, and 11% in journals with Impact Factors > 10. These positive developments demonstrate the renewed strength of FCCC and the importance of its role in the care of cancer patients in this region.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = -$174,848 )
2024	2022	THE INSTITUTE FOR CANCER RESEARCH	333 COTTMAN AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Centers Support Grants	000	55	10/1/2023	SUPPLEMENT FOR EXPANSION	-$174,848
2024	2020	THE INSTITUTE FOR CANCER RESEARCH	333 COTTMAN AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Centers Support Grants	001	55	9/18/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = -$174,848

Issue Date FY: 2023 ( Subtotal = $0 )
2023	2020	INSTITUTE FOR CANCER RESEARCH, THE	333 COTTMAN AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Centers Support Grants	000	55	6/29/2023	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2022 ( Subtotal = $650,000 )
2022	2022	INSTITUTE FOR CANCER RESEARCH, THE	333 COTTMAN AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Centers Support Grants	011	55	5/13/2022	SUPPLEMENT FOR EXPANSION	$400,000
2022	2022	INSTITUTE FOR CANCER RESEARCH, THE	333 COTTMAN AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Centers Support Grants	016	55	8/2/2022	SUPPLEMENT FOR EXPANSION	$0
2022	2022	INSTITUTE FOR CANCER RESEARCH, THE	333 COTTMAN AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Centers Support Grants	017	55	8/3/2022	SUPPLEMENT FOR EXPANSION	$0
2022	2022	INSTITUTE FOR CANCER RESEARCH, THE	333 COTTMAN AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Centers Support Grants	010	55	5/12/2022	SUPPLEMENT FOR EXPANSION	$250,000
2022	2021	INSTITUTE FOR CANCER RESEARCH, THE	333 COTTMAN AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Centers Support Grants	007	55	1/31/2022	SUPPLEMENT FOR EXPANSION	$0
2022	2021	INSTITUTE FOR CANCER RESEARCH, THE	333 COTTMAN AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Centers Support Grants	008	55	2/1/2022	SUPPLEMENT FOR EXPANSION	$0
2022	2021	INSTITUTE FOR CANCER RESEARCH, THE	333 COTTMAN AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Centers Support Grants	006	55	1/28/2022	SUPPLEMENT FOR EXPANSION	$0
2022	2021	INSTITUTE FOR CANCER RESEARCH, THE	333 COTTMAN AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Centers Support Grants	009	55	2/3/2022	SUPPLEMENT FOR EXPANSION	$0
2022	2021	INSTITUTE FOR CANCER RESEARCH, THE	333 COTTMAN AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Centers Support Grants	014	55	7/29/2022	SUPPLEMENT FOR EXPANSION	$0
2022	2021	INSTITUTE FOR CANCER RESEARCH, THE	333 COTTMAN AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Centers Support Grants	000	55	1/4/2022	SUPPLEMENT FOR EXPANSION	$0
2022	2021	INSTITUTE FOR CANCER RESEARCH, THE	333 COTTMAN AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Centers Support Grants	015	55	8/1/2022	SUPPLEMENT FOR EXPANSION	$0
2022	2021	INSTITUTE FOR CANCER RESEARCH, THE	333 COTTMAN AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Centers Support Grants	001	55	1/5/2022	SUPPLEMENT FOR EXPANSION	$0
2022	2020	INSTITUTE FOR CANCER RESEARCH, THE	333 COTTMAN AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Centers Support Grants	013	55	7/28/2022	SUPPLEMENT FOR EXPANSION	$0
2022	2020	INSTITUTE FOR CANCER RESEARCH, THE	333 COTTMAN AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Centers Support Grants	004	55	1/26/2022	SUPPLEMENT FOR EXPANSION	$0
2022	2020	INSTITUTE FOR CANCER RESEARCH, THE	333 COTTMAN AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Centers Support Grants	012	55	7/27/2022	NON-COMPETING CONTINUATION	$0
2022	2020	INSTITUTE FOR CANCER RESEARCH, THE	333 COTTMAN AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Centers Support Grants	005	55	1/27/2022	SUPPLEMENT FOR EXPANSION	$0
2022	2020	INSTITUTE FOR CANCER RESEARCH, THE	333 COTTMAN AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Centers Support Grants	002	55	1/25/2022	NON-COMPETING CONTINUATION	$0
2022	2020	INSTITUTE FOR CANCER RESEARCH, THE	333 COTTMAN AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Centers Support Grants	003	55	1/25/2022	SUPPLEMENT FOR EXPANSION	$0
														Subtotal = $650,000

Issue Date FY: 2021 ( Subtotal = $1,685,145 )
2021	2021	INSTITUTE FOR CANCER RESEARCH, THE	333 COTTMAN AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Centers Support Grants	002	55	9/13/2021	SUPPLEMENT FOR EXPANSION	$250,000
2021	2021	INSTITUTE FOR CANCER RESEARCH, THE	333 COTTMAN AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Centers Support Grants	000	55	1/6/2021	SUPPLEMENT FOR EXPANSION	$400,000
2021	2021	INSTITUTE FOR CANCER RESEARCH, THE	333 COTTMAN AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Centers Support Grants	001	55	9/10/2021	SUPPLEMENT FOR EXPANSION	$1,035,145
														Subtotal = $1,685,145

Issue Date FY: 2020 ( Subtotal = $4,086,686 )
2020	2020	INSTITUTE FOR CANCER RESEARCH, THE	333 COTTMAN AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Centers Support Grants	002	55	8/20/2020	SUPPLEMENT FOR EXPANSION	$140,250
2020	2020	INSTITUTE FOR CANCER RESEARCH, THE	333 COTTMAN AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Centers Support Grants	003	55	8/24/2020	SUPPLEMENT FOR EXPANSION	$250,000
2020	2020	INSTITUTE FOR CANCER RESEARCH, THE	333 COTTMAN AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Centers Support Grants	004	55	9/16/2020	SUPPLEMENT FOR EXPANSION	$391,000
2020	2020	INSTITUTE FOR CANCER RESEARCH, THE	333 COTTMAN AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Centers Support Grants	000	54	3/20/2020	SUPPLEMENT FOR EXPANSION	$200,000
2020	2020	INSTITUTE FOR CANCER RESEARCH, THE	333 COTTMAN AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Centers Support Grants	001	55	8/14/2020	NON-COMPETING CONTINUATION	$3,105,436
														Subtotal = $4,086,686

Issue Date FY: 2019 ( Subtotal = $3,695,686 )
2019	2019	INSTITUTE FOR CANCER RESEARCH, THE	333 COTTMAN AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Centers Support Grants	005	54	8/23/2019	SUPPLEMENT FOR EXPANSION	$0
2019	2019	INSTITUTE FOR CANCER RESEARCH, THE	333 COTTMAN AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Centers Support Grants	004	54	8/20/2019	SUPPLEMENT FOR EXPANSION	$200,000
2019	2019	INSTITUTE FOR CANCER RESEARCH, THE	333 COTTMAN AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Centers Support Grants	002	54	8/16/2019	SUPPLEMENT FOR EXPANSION	$140,250
2019	2019	INSTITUTE FOR CANCER RESEARCH, THE	333 COTTMAN AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Centers Support Grants	001	54	8/15/2019	NON-COMPETING CONTINUATION	$2,905,436
2019	2019	INSTITUTE FOR CANCER RESEARCH, THE	333 COTTMAN AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Centers Support Grants	003	54	8/19/2019	SUPPLEMENT FOR EXPANSION	$250,000
2019	2019	INSTITUTE FOR CANCER RESEARCH, THE	333 COTTMAN AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Centers Support Grants	000	53	3/12/2019	SUPPLEMENT FOR EXPANSION	$200,000
														Subtotal = $3,695,686

Issue Date FY: 2018 ( Subtotal = $3,270,527 )
2018	2018	INSTITUTE FOR CANCER RESEARCH, THE	333 COTTMAN AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Centers Support Grants	000	53	8/1/2018	NON-COMPETING CONTINUATION	$2,758,277
2018	2018	INSTITUTE FOR CANCER RESEARCH, THE	333 COTTMAN AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Centers Support Grants	001	53	8/6/2018	SUPPLEMENT FOR EXPANSION	$137,250
2018	2018	INSTITUTE FOR CANCER RESEARCH, THE	333 COTTMAN AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Centers Support Grants	003	53	9/25/2018	SUPPLEMENT FOR EXPANSION	$125,000
2018	2018	INSTITUTE FOR CANCER RESEARCH, THE	333 COTTMAN AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Centers Support Grants	002	53	9/13/2018	SUPPLEMENT FOR EXPANSION	$250,000
														Subtotal = $3,270,527

Issue Date FY: 2017 ( Subtotal = $3,276,084 ) (Continued on the next page)
2017	2017	INSTITUTE FOR CANCER RESEARCH, THE	333 COTTMAN AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Centers Support Grants	004	52	9/4/2017	NON-COMPETING CONTINUATION	$51,260
2017	2017	INSTITUTE FOR CANCER RESEARCH, THE	333 COTTMAN AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Centers Support Grants	003	52	9/2/2017	SUPPLEMENT FOR EXPANSION	$125,000
2017	2017	INSTITUTE FOR CANCER RESEARCH, THE	333 COTTMAN AVE	PHILADELPHIA	PA	19111	PHILADELPHIA	USA	Cancer Centers Support Grants	000	52	7/27/2017	NON-COMPETING CONTINUATION	$2,712,574
Grand Total All Awards = $144,068,545

Page 1 of 3 (147 items)12 3

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Comprehensive Cancer Center Program at Fox Chase

Award Number: P30CA006927

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer